J7608 HCPCS code: Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
J7608 is the HCPCS Level II code for acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram. In 2024 Medicare paid an average of $5.76 per service for J7608 across 50 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 222 per day on DME suppliers. Medicare volume fell 66% from 2022 to 2024 (149 to 50 services). In 2024, about 10 clinicians billed Medicare for J7608 for 26 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | D1G — Drugs administered through DME |
| Added | 2000-01-01 |
| Last action effective | 2008-01-01 |
Who bills J7608 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 10 |
| Medicare beneficiaries | 26 |
| States with claims | 1 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7608, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 149 | 57 | $4.96 | $3.88 |
| 2023 | 107 | 38 | $4.67 | $3.72 |
| 2024 | 50 | 26 | $7.49 | $5.76 |
States with the most J7608 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Georgia | 28 | $6.30 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 222 | Published Contractor Policy |
| practitioner claims | 3 | Clinical: Data |
What changed for J7608
- 2000-01-01: J7608 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7608?
J7608 is the HCPCS Level II code for acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram. Short descriptor: "Acetylcysteine non-comp unit".
How much does Medicare pay for J7608?
In 2024, the average Medicare payment was $5.76 per service (average allowed $7.49).
Does Medicare cover J7608?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J7608 can be billed per day?
222 on DME suppliers; 3 on practitioner claims (NCCI medically unlikely edits).
Related J76 codes
- J7601 — Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
- J7604 — Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
- J7605 — Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
- J7606 — Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
- J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
- J7609 — Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
- J7610 — Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
- J7611 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
- J7612 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
- J7613 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
- J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
- J7615 — Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7608
- Watch J7608 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7608
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.